Prebet T - Search Results

1

Evaluation of comorbidity indexes in the outcome of elderly patients treated for acute lymphoblastic leukemia.

Saillard C, Etienne A, Charbonnier A, D'incan E, Rey J, Arnoulet C, Mozziconacci MJ, Blaise D, Vey N, Prebet T. Saillard C, et al. Among authors: prebet t. Leuk Lymphoma. 2014 Sep;55(9):2211-2. doi: 10.3109/10428194.2013.876497. Epub 2014 Jan 28. Leuk Lymphoma. 2014. PMID: 24354683 No abstract available.

2

Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001.

Ravandi F, Döhner H, Wei AH, Montesinos P, Pfeilstöcker M, Papayannidis C, Lai Y, Wang K, See WL, de Menezes DL, Petrlik E, Prebet T, Roboz GJ. Ravandi F, et al. Among authors: prebet t. Br J Haematol. 2024 Mar;204(3):877-886. doi: 10.1111/bjh.19202. Epub 2023 Nov 12. Br J Haematol. 2024. PMID: 37952982

3

Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literature.

Mozziconacci MJ, Carbuccia N, Prebet T, Charbonnier A, Murati A, Vey N, Chaffanet M, Birnbaum D. Mozziconacci MJ, et al. Among authors: prebet t. Leuk Res. 2008 Aug;32(8):1304-8. doi: 10.1016/j.leukres.2007.11.012. Epub 2007 Dec 21. Leuk Res. 2008. PMID: 18096225 Review.

4

Presence of a minor Philadelphia-positive clone in young adults with de novo T-cell ALL.

Prebet T, Mozziconacci MJ, Sainty D, Arnoulet C, Lafage M, Dastugue N, Charbonnier A, Coso D, Gastaut JA, Blaise D, Vey N. Prebet T, et al. Leuk Lymphoma. 2009 Mar;50(3):485-7. doi: 10.1080/10428190802601148. Leuk Lymphoma. 2009. PMID: 19197723 No abstract available.

5

Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.

Gelsi-Boyer V, Trouplin V, Adélaïde J, Bonansea J, Cervera N, Carbuccia N, Lagarde A, Prebet T, Nezri M, Sainty D, Olschwang S, Xerri L, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D. Gelsi-Boyer V, et al. Among authors: prebet t. Br J Haematol. 2009 Jun;145(6):788-800. doi: 10.1111/j.1365-2141.2009.07697.x. Epub 2009 Apr 15. Br J Haematol. 2009. PMID: 19388938 Free article.

6

Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation.

Chevallier P, Prebet T, Turlure P, Hunault M, Vigouroux S, Harousseau JL, Blaise D, Ifrah N, Milpied N, Mohty M. Chevallier P, et al. Among authors: prebet t. Bone Marrow Transplant. 2010 Jan;45(1):165-70. doi: 10.1038/bmt.2009.153. Epub 2009 Jul 6. Bone Marrow Transplant. 2010. PMID: 19584826

7

Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.

Prébet T, Boissel N, Reutenauer S, Thomas X, Delaunay J, Cahn JY, Pigneux A, Quesnel B, Witz F, Thépot S, Ugo V, Terre C, Recher C, Tavernier E, Hunault M, Esterni B, Castaigne S, Guilhot F, Dombret H, Vey N; Acute Leukemia French Association; Groupe Ouest-Est des leucémies et autres maladies du sang (GOELAMS); Core Binding Factor Acute Myeloid Leukemia (CBF AML) intergroup. Prébet T, et al. J Clin Oncol. 2009 Oct 1;27(28):4747-53. doi: 10.1200/JCO.2008.21.0674. Epub 2009 Aug 31. J Clin Oncol. 2009. PMID: 19720919

8

Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation.

Prébet T, Ladaique P, Ferrando M, Chabannon C, Faucher C, De Lavallade H, El-Cheikh J, Furst S, Vey N, Stoppa AM, Viens P, Blaise D, Mohty M. Prébet T, et al. Exp Hematol. 2010 Jan;38(1):55-60. doi: 10.1016/j.exphem.2009.10.004. Exp Hematol. 2010. PMID: 19837124 Free article.

9

Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin.

Chevallier P, Prebet T, Pigneux A, Hunault M, Delaunay J, Perry F, Lode L, Richebourg S, Blanchet O, Vey N, Ifrah N, Milpied N, Blaise D, Harousseau JL, Mohty M. Chevallier P, et al. Among authors: prebet t. Leukemia. 2010 Feb;24(2):467-9. doi: 10.1038/leu.2009.214. Epub 2009 Oct 22. Leukemia. 2010. PMID: 19847200 No abstract available.

10

Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioning.

Prébet T, Devillier R, Fürst S, Vey N, Blaise D. Prébet T, et al. Bone Marrow Transplant. 2010 Oct;45(10):1574-5. doi: 10.1038/bmt.2010.16. Epub 2010 Feb 22. Bone Marrow Transplant. 2010. PMID: 20173783 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters